NEW DELHI, INDIA - August 21, 2018 - GE Power (NYSE: GE) today announced that it has been selected by BHEL (Bharat Heavy Electricals Limited) for the supply of one 6F.03 gas turbine and a generator for ins
Schenectady, NY (August 14, 2018)-Today TerraForm Power, Inc. (“TerraForm”) announced that GE Renewable Energy has been selected to provide a range of services for its North American wind fleet, one of the region’s largest with more than 900 turbines.
Norwalk, Connecticut - August 8, 2018: GE Capital (NYSE:GE) has entered into an agreement to sell its GE Energy Financial Services’ Project Finance Debt Business (“Project Finance Debt Business”), including the transfer of a team of employees, to Starwood Property Trust, Inc. (NYSE: STWD) (“Starwood”). The sale comes as the energy investing unit of GE seeks to reduce the size of its asset base in support of a smaller and more focused GE Capital.
London, UK - July 18, 2018 - GE (NYSE: GE) facilitated an alternative financing package for Atlas Air, Inc. (“Atlas Air”), a subsidiary of Atlas Air Worldwide Holdings, Inc. (Nasdaq: AAWW), a leading global provider of outsourced aircraft and aviation operating services.
Boston, MA, USA -July 16, 2018 - GE Healthcare is launching OmnipaqueTM (iohexol) Oral Solution in the United States, a new, ready-to-drink iodinated contrast medium that can be used to help physicians diagnose medical conditions by improving the diagnostic visualization of the abdominal gastrointestinal tract.
Omnipaque oral solution is indicated for oral use only in conjunction with Omnipaque injection administered intravenously for computed tomography (CT) of the abdomen in adults and children.
